In conclusion, NSE and SCC levels in serum can effectively reflect the radiotherapy effect of lung cancer patients and show a certain predictive value for the prognosis effect after radiotherapy, providing information for the clinical radiotherapy effect and prognosis, and the basis and guidance for further clinical treatment. The gene discussed is SERPINB3; the disease is lung carcinoma.